Physician Profile
Based in Hanover, PA, James A. Dicke, M.D. is listed in the NPI registry under endocrinology, diabetes & metabolism. James graduated from University of Maryland School of Medicine in 1986. According to Medicare claims data, James cared for 1,124 Medicare patients across 4,213 services. The services billed most often include injection, denosumab, 1 mg, established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, and hemoglobin a1c level.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
2201 BRUNSWICK DR STE 2300
Hanover, PA 17331
Within Endocrinology, Diabetes and Metabolism generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Adrenal
Adrenal disorders
Blood sugar disorders
Bone and calcium disorders
Bones
Diabetes
Endocrine tumors
Hormone disorders
Hormones
Metabolic disorders
Metabolism
Parathyroid
Pituitary
Pituitary disorders
Thyroid
Thyroid disorders
Most searched procedures
Adrenal
Adrenal evaluations
Blood sugar management
Bone evaluations
Bone treatments
Diabetes
Diabetes education
Diabetes preventive care
Genetic evaluations
Hormone treatments
Hormones
Metabolic evaluations
Metabolism
Parathyroid
Pituitary
Pituitary evaluations
Thyroid
Thyroid procedures
Weight & Metabolism
4,213 services · 1,124 patients · 9 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Treatment | 95251 |
122 |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
70 |
| Injection, denosumab, 1 mg | Drug given | J0897 |
2,280 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
1,081 |
| Hemoglobin a1c level | Lab test | 83036 |
467 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office visit | 99211 |
127 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | Office visit | 99215 |
40 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient' | Billing code | G2211 |
14 |
| Telephone medical discussion with physician, 21-30 minutes | Office visit | 99443 |
12 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
James A. Dicke is an endocrinologist in Hanover, PA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Endocrinology, Diabetes & Metabolism”.
NPI registry
James A. Dicke is listed at 2201 Brunswick Dr Ste 2300, Hanover, PA 17331. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (717) 316-3670. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
James A. Dicke's National Provider Identifier is 1497737928. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
James A. Dicke attended University of Maryland School of Medicine, graduating in 1986. This comes from the CMS National Downloadable File.
CMS public data
James A. Dicke has 40 years experience. Calculated from a graduation year of 1986, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, James A. Dicke provides treatments such as continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report and injection of drug or substance under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by James A. Dicke. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.